• Areas of Focus
    • TeamBirth
    • OB Readiness in the ED
    • Perinatal Substance Use and Mental Health
    • Maternal Morbidity and Mortality
    • Low Dose Aspirin
    • Empowering Pregnant and Postpartum Patients
    • Infant Mortality
    • Newborn Screening
    • Therapeutic Hypothermia
    • Congenital Syphilis
    • Hospital Recognition
    • Completed Initiatives
  • Professionals
    • Resources
    • OPNF
    • Legislation
  • Patients
    • Resources
    • Lived Experience Program
    • Map Directory
  • About
    • Faculty and Staff
    • Contact Us
  • Events
    • OPQIC Upcoming Events
    • OPQIC Summit 2024
    • Event Recordings
  • What’s New
    • Subscribe to our Newsletter
    • Newsletter Archives
    • OPQIC in the News

AAP Clinical Report: Neonatal Opioid Withdrawal Syndrome

AAP Clinical Report: Neonatal Opioid Withdrawal Syndrome

Category: AAP, Newsletter, OMNOTags: NAS, neonatal abstinence syndrome, nows, opioids, withdrawal
October 30, 2020

From AAP News –

A new AAP clinical report gives pediatric providers the information and tools to improve care of infants born with NOWS and serves as a companion to a 2012 report on neonatal drug withdrawal.

The clinical report Neonatal Opioid Withdrawal Syndrome, from the Committee on Fetus and Newborn and Committee on Substance Use and Prevention, is available at https://pediatrics.aappublications.org/content/early/2020/10/10/peds.2020-029074 and will be published in the November issue of Pediatrics.

Click here to access the clinical report.

Click here for the AAP news article describing the report.

Post navigation

PreviousNext

Recent Posts

  • MCN: Effective Communication During and After an Amniotic Fluid Embolism
  • AJOG: Comparative effectiveness of treating prenatal depression with counseling versus antidepressants in relation to preterm delivery
  • AAP: Hospital Practices and Policies for Neonatal Abstinence Syndrome in the United States, 2022
  • Midwifery: An exploration of women’s decision-making processes around accepting or declining vaccinations in pregnancy: A qualitative descriptive study
  • AJOG: Evidence that systemic vascular resistance is increased before the development of gestational diabetes mellitus

Oklahoma Hospital Association
4000 N. Lincoln Blvd.
Oklahoma City, OK 73105
  • Patients
    • Patient Resources
    • Lived Experience
    • Resource Map
    • OPQIC Initiatives
  • Professionals
    • What's New
    • Resources
    • OPNF
  • Initiatives
    • TeamBirth
    • OB Readiness in the ED
    • OMNO
    • Infant Mortality
  • About
    • Contact Us
    • Subscribe
Sign up for our monthly newsletter
Sitemap | © 2014-2025 Oklahoma Perinatal Quality Improvement Collaborative. All Rights Reserved.